Prescription for recovery in FY23 for underperforming pharma sector - News Summed Up

Prescription for recovery in FY23 for underperforming pharma sector


The Index was the second-worst performer among Nifty sectoral indices over the past year, shedding over 13 per cent in trade. Over a two-year period, its underperformance has grown starker. It is the only index to generate a mid single-digit return (6 per cent), with its closest competitor enriching investors by over 35 per cent.


Source: Wall Street Journal September 26, 2022 00:45 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */